Please login to the form below

Not currently logged in

Jeffrey Gold appointed CEO of myoscience

Previously worked as president and COO at the firm
Jeffrey Gold

Jeffrey Gold has been named as CEO of medical device company myoscience.

Gold has previously held the positions of president and chief operating officer at the company. Previously he has held posts as chief executive for Velomedix and CryoVascular Systems as well as being chief operating officer for CardioThoracic Systems.

Concerning his appointment, Gold commented: “I am very excited to assume the responsibility of guiding myoscience through its next development stage. The myoscience tea has built an extremely strong platform technology that targets two distinct markets, aesthetics and peripheral nerve pain.

“We have a strong team of dedicated professionals that will drive myoscience to greater success in the future.”

Prior to his roles at Velomedix, Gold was a venture partner for Longitude Capital where he focused on investments in medical devices.

Rich Ferrari, myoscience executive chairman, added: “Jeff is a seasoned executive with a solid record of success. The myoscience board of directors fully supports the appointment and we are excited to have Jeff accept the leadership role as CEO.”

28th November 2014


Featured jobs

Subscribe to our email news alerts


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

When is it time to rebrand?
The Biosimilar Challenge
How health behaviours and clinical outcomes are related
When HCPs understand patient activation levels they can actively guide patients towards more confident self-management of diverse health concerns....